查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587425

神經血管設備市場規模、佔有率、趨勢分析報告：按設備、按治療應用、按規模、按最終用途、按地區、按細分市場、預測，2025-2030 年

Neurovascular Devices Market Size, Share & Trends Analysis Report By Device (Neurothrombectomy Devices, Support Devices), By Therapeutic Application (Stroke, Cerebral Artery Stenosis), By Size, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

神經血管設備市場成長與趨勢

Grand View Research, Inc.最新報告顯示，預計2030年全球神經血管器械市場規模將達45.3億美元，2025年至2030年複合年成長率為6.01%。

中風、腦動脈瘤和腦動脈狹窄等神經系統疾病盛行率的上升正在推動神經血管設備市場的成長。根據世界中風組織 (WSO) 的數據，到 2022 年，每年新增中風人數將超過 1,220 萬例。

25 歲以上的成年人中，四分之一的人一生中都會中風。每年約有 760 萬新發生缺血性中風病例。全球約62.0%的中風是缺血性中風，每年新增超過120萬例蜘蛛網膜下腔出血。因此，數據顯示，對神經血管設備的需求龐大，這正在推動神經血管設備市場的擴張。

在已開發國家和新興國家，腦動脈瘤的盛行率不斷上升，這是將技術先進的產品引入市場的驅動力。顱內動脈瘤的重要治療技術包括手術夾閉、血管內卷取和分流器。市場參與企業不斷努力將技術先進的產品推向市場。

例如，2021 年 9 月，美敦力公司 (Medtronic plc) 宣布其橈動脈通路產品組合獲得 CE 標誌批准，其中包括 Rist 079 橈動脈通路導管和 Access Rist 橈動脈選擇性導管。此外，2022年3月，微創科學公司宣布其Hyperflex球囊導管獲得美國藥品和醫療設備管理局（PMDA）的註冊核准。

減少術後不適和加速恢復是擴大微創手術使用並刺激該領域研究和開發的因素。血管內卷取是一種微創手術，臨床醫師常提案用於治療腦動脈瘤。與白金裸彈簧圈相比，Hydrocoils（MicroVention，Tustin，CA，美國）的復發率較低，並且可以治療更複雜的動脈瘤結構。因此，對微創治療的需求不斷成長，支持了神經血管設備市場的擴張。

神經血管設備市場報告亮點

  • 腦栓塞/動脈瘤彈簧圈彈簧圈裝置佔最大市場佔有率，2024年約36.02%。彈簧圈栓塞是一種用於治療動脈瘤的微創手術，其中材料封閉囊並降低出血風險。
  • 由於高血壓、中風和其他神經系統疾病盛行率增加等因素，中風在2024年佔據最大的市場佔有率，約為56.86%。
  • 0.021吋佔最大市場佔有率，2024年約27.08%。該細分市場的成長歸功於 0.021 吋設備提供的各種優勢以及各種產品的發布和產品核可。
  • 2024年，醫院佔最大市場佔有率，約70.79%。據信，這一領域的成長主要是由於患有神經血管疾病的患者數量不斷增加，例如缺血性和出血性中風、腦動脈瘤、創傷性腦損傷（TBI）和動靜脈畸形（AVM）。
  • 由於 Penumbra, Inc.、Stryker Corporation、Johnson & Johnson、Merit Medical Systems, Inc. 等主要製造商的存在，北美神經血管設備在 2024 年以 27.62% 的佔有率佔據市場主導地位。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 神經血管裝置的變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 神經血管設備分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第 4 章 神經血管設備市場：2018-2030 年按設備分類的細分分析（百萬美元和銷售單位）

  • 定義和範圍
  • 2024 年及 2030 年設備市場佔有率分析
  • 全球神經血管設備市場（按設備），2018-2030
  • 2018-2030年市場規模、預測與趨勢分析

第 5 章 神經血管設備市場：2018-2030 年按治療應用分類的細分分析（百萬美元）

  • 定義和範圍
  • 2024 年和 2030 年治療應用市場佔有率分析
  • 全球神經血管設備市場（依治療應用），2018-2030
  • 2018-2030年市場規模、預測與趨勢分析

第6章神經血管設備市場：細分分析，依規模，2018-2030（百萬美元）

  • 定義和範圍
  • 2024 年及 2030 年規模市場佔有率分析
  • 全球神經血管設備市場（依規模），2018-2030
  • 2018-2030年市場規模、預測與趨勢分析

第 7 章 神經血管設備市場：2018-2030 年依最終用途分類的細分分析（百萬美元）

  • 定義和範圍
  • 2024 年及 2030 年最終用途市場佔有率分析
  • 全球神經血管設備市場（依最終用途），2018-2030 年
  • 2018-2030年市場規模、預測與趨勢分析

第8章神經血管設備市場：按地區估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 市場參與企業分類
  • 主要市場參與企業的最新趨勢和影響分析
  • 2024 年企業市場佔有率分析
  • 主要企業簡介
    • Medtronic
    • Stryker Corporation
    • Terumo Corporation
    • Penumbra, Inc.
    • Johnson & Johnson Services, Inc.
    • Integra LifeSciences Corporation
    • Acandis GmbH
    • Spiegelberg GmbH &Co. KG
    • MicroPort Scientific Corporation
    • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Product Code: GVR-2-68038-851-0

Neurovascular Devices Market Growth & Trends:

The global neurovascular devices market size is expected to reach USD 4.53 billion by 2030, registering a CAGR of 6.01% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of neurological illnesses such as stroke, brain aneurysm, and cerebral artery stenosis is driving growth of the neurovascular devices market. According to the World Stroke Organization (WSO), in 2022, there will be more than 12.2 million new strokes per year.

One in every four adults above the age of 25 will suffer a stroke throughout their lifetime. In addition, nearly 7.6 million new ischemic strokes occur each year. Around 62.0% of all incident strokes worldwide are ischemic strokes, with more than 1.2 million new subarachnoid hemorrhages occurring each year. As a result, the figures show that there is a significant demand for the neurovascular devices, which is driving neurovascular device market expansion.

The rising prevalence of brain aneurysms in both developed and developing countries is driving the introduction of technologically advanced products to the market. Some significant therapeutic techniques for an intracranial aneurysm include surgical clipping, endovascular coiling, and flow diverters. Market participants are constantly working to introduce technologically advanced products to the market.

For instance, in September 2021, Medtronic plc. announced the CE Mark clearance of its radial artery access portfolio, which comprises the Rist 079 Access Radial Guide Catheter and the Access Rist Radial Selective Catheter. Furthermore, in March 2022, Micro Port Scientific Company announced that its Hyper flex Balloon Catheter has received registration approval from the Japan Pharmaceuticals and Medical Devices Agency (PMDA).

Reduced postoperative discomfort and faster recovery are the factors expanding use of the minimally invasive operations and fueling R&D in this field. Endovascular coiling is a minimally invasive surgery that is frequently suggested by the clinicians for the treatment of cerebral aneurysms. Hydro Coils (MicroVention, Tustin, California, USA) have permitted the treatment of more complex aneurysmal structures with reduced recurrence rates as compared to bare-platinum coils. As a result, increased demand for the minimally invasive procedures is supporting neurovascular device market expansion.

Neurovascular Devices Market Report Highlights:

  • Cerebral embolization and aneurysm coiling devices held the largest market share of around 36.02% in 2024. Coil embolization is a minimally invasive procedure for the treatment of aneurysms, wherein, the material closes the sac and reduces the risk of bleeding.
  • Stroke held the largest market share of around 56.86% in 2024, owing to the factors such as increasing prevalence of hypertension, stroke, and other neurological disorders.
  • 0.021" held the largest market share of around 27.08% in 2024. Segment growth can be attributed to various advantages provided by the 0.021" devices, along with various product launches and product approvals.
  • Hospitals held the largest market share of around 70.79% in 2024. The growth of this segment can be attributed primarily to the increasing patient pool suffering from neurovascular disorders, such as ischemic & hemorrhagic stroke, brain aneurysm, Traumatic brain injury (TBI), and Arteriovenous Malformation (AVM).
  • North America neurovascular devices dominated the market with a share of 27.62% in 2024 owing to the presence of key manufacturers such as Penumbra, Inc., Stryker Corporation, Johnson & Johnson, and Merit medical systems, Inc. in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Device
    • 1.2.2. Therapeutic Applications
    • 1.2.3. Size
    • 1.2.4. End Use
    • 1.2.5. Regional Scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Neurovascular Devices Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Neurovascular Diseases
      • 3.2.1.2. Technological Advancements In Neurovascular Devices
      • 3.2.1.3. Rising Number of Awareness Initiatives
      • 3.2.1.4. Increasing Demand For Minimally Invasive Procedures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Product Recalls
      • 3.2.2.2. High Treatment Cost Associated With Neurovascular Disorders
  • 3.3. Neurovascular Devices Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Neurovascular Devices Market: Segment Analysis, By Device, 2018 - 2030 (USD Million and Volume Unit)

  • 4.1. Definition and Scope
  • 4.2. Device Market Share Analysis, 2024 & 2030
  • 4.3. Global Neurovascular Devices Market, by Device, 2018 to 2030
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.4.1. Cerebral Embolization and Aneurysm coiling devices
      • 4.4.1.1. Cerebral embolization and aneurysm coiling devices market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.1.2. Embolic coils
        • 4.4.1.2.1. Embolic coils market, 2018 - 2030 (USD Million)
      • 4.4.1.3. Flow diverters
        • 4.4.1.3.1. Flow diverters market, 2018 - 2030 (USD Million)
      • 4.4.1.4. Liquid embolic agents
        • 4.4.1.4.1. Liquid embolic agents market, 2018 - 2030 (USD Million)
    • 4.4.2. Cerebral angioplasty and stenting sytems
      • 4.4.2.1. Cerebral angioplasty and stenting sytems market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.2.2. Carotid Artery Stents
        • 4.4.2.2.1. Carotid artery stents market, 2018 - 2030 (USD Million)
      • 4.4.2.3. Embolic Protection Devices
        • 4.4.2.3.1. Embolic protection systems devices market, 2018 - 2030 (USD Million)
    • 4.4.3. Neurothrombectomy devices
      • 4.4.3.1. Neurothrombectomy devices market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.3.2. Clot Retrieval Devices
        • 4.4.3.2.1. Clot retrieval devices market, 2018 - 2030 (USD Million)
      • 4.4.3.3. Suction Devices
        • 4.4.3.3.1. Suction devices market, 2018 - 2030 (USD Million)
      • 4.4.3.4. Vascular Snares
        • 4.4.3.4.1. Vascular snares market, 2018 - 2030 (USD Million)
    • 4.4.4. Support devices
      • 4.4.4.1. Support devices market, 2018 - 2030 (USD Million and Volume Unit)
      • 4.4.4.2. Micro Catheters
        • 4.4.4.2.1. Micro catheters market, 2018 - 2030 (USD Million)
      • 4.4.4.3. Micro Guidewires
        • 4.4.4.3.1. Micro guidewires market, 2018 - 2030 (USD Million)
    • 4.4.5. Trans Radial Access Devices
      • 4.4.5.1. Trans radial access devices market, 2018 - 2030 (USD Million and Volume Unit)

Chapter 5. Neurovascular Devices Market: Segment Analysis, By Therapeutic Applications, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Therapeutic Applications Market Share Analysis, 2024 & 2030
  • 5.3. Global Neurovascular Devices Market, by Therapeutic Applications, 2018 to 2030
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.4.1. Stroke
      • 5.4.1.1. Stroke market, 2018 - 2030 (USD Million)
    • 5.4.2. Cerebral artery stenosis
      • 5.4.2.1. Cerebral artery stenosis market, 2018 - 2030 (USD Million)
    • 5.4.3. Cerebral aneurysm
      • 5.4.3.1. Cerebral aneurysm market, 2018 - 2030 (USD Million)
      • 5.4.3.2. Aneurysmal Subarachnoid Hemorrhage
        • 5.4.3.2.1. Aneurysmal subarachnoid hemorrhage market, 2018 - 2030 (USD Million)
      • 5.4.3.3. Others
        • 5.4.3.3.1. Others market, 2018 - 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others market, 2018 - 2030 (USD Million)

Chapter 6. Neurovascular Devices Market: Segment Analysis, By Size, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Size Market Share Analysis, 2024 & 2030
  • 6.3. Global Neurovascular Devices Market, by Size, 2018 to 2030
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.4.1. 0.027"
      • 6.4.1.1. 0.027" market, 2018 - 2030 (USD Million)
    • 6.4.2. 0.021"
      • 6.4.2.1. 0.021" market, 2018 - 2030 (USD Million)
    • 6.4.3. 0.071"
      • 6.4.3.1. 0.071" market, 2018 - 2030 (USD Million)
    • 6.4.4. 0.017"
      • 6.4.4.1. 0.017" market, 2018 - 2030 (USD Million)
    • 6.4.5. 0.019"
      • 6.4.5.1. 0.019" market, 2018 - 2030 (USD Million)
    • 6.4.6. 0.013"
      • 6.4.6.1. 0.013" market, 2018 - 2030 (USD Million)
    • 6.4.7. 0.058"
      • 6.4.7.1. 0.058" market, 2018 - 2030 (USD Million)
    • 6.4.8. 0.068"
      • 6.4.8.1. 0.068" market, 2018 - 2030 (USD Million)
    • 6.4.9. Others
      • 6.4.9.1. Others market, 2018 - 2030 (USD Million)

Chapter 7. Neurovascular Devices Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 7.1. Definition and Scope
  • 7.2. End Use Market Share Analysis, 2024 & 2030
  • 7.3. Global Neurovascular Devices Market, by End Use, 2018 to 2030
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 7.4.1. Hospital
      • 7.4.1.1. Hospital market, 2018 - 2030 (USD Million)
    • 7.4.2. Specialty clinics
      • 7.4.2.1. Specialty clinics market, 2018 - 2030 (USD Million)
    • 7.4.3. Others
      • 7.4.3.1. Others market, 2018 - 2030 (USD Million)

Chapter 8. Neurovascular Devices Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. Mexico
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Recent Developments & Impact Analysis by Key Market Participants
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. Key Company Profiles
    • 9.4.1. Medtronic
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Stryker Corporation
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Terumo Corporation
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Penumbra, Inc.
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Johnson & Johnson Services, Inc.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Integra LifeSciences Corporation
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Acandis GmbH
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Spiegelberg GmbH & Co. KG
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. MicroPort Scientific Corporation
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America neurovascular devices market, by country, 2018 - 2030 (USD Million)
  • Table 4. North America neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 5. North America neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 6. North America neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 7. North America neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 8. U.S. neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 9. U.S. neurovascular devices, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 10. U.S. neurovascular devices, by size, 2018 - 2030 (USD Million)
  • Table 11. U.S. neurovascular devices, by end use, 2018 - 2030 (USD Million)
  • Table 12. Canada neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 13. Canada neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 14. Canada neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 15. Canada neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 16. Europe neurovascular devices market, by country, 2018 - 2030 (USD Million)
  • Table 17. Europe neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 18. Europe neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 19. Europe neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 20. Europe neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 21. UK neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 22. UK neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 23. UK neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 24. UK neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 25. Germany neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 26. Germany neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 27. Germany neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 28. Germany neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 29. France neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 30. France neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 31. France neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 32. France neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 33. Italy neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 34. Italy neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 35. Italy neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 36. Italy neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 37. Spain neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 38. Spain neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 39. Spain neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 40. Spain neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 41. Norway neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 42. Norway neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 43. Norway neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 44. Norway neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 45. Sweden neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 46. Sweden neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 47. Sweden neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 48. Sweden neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 49. Denmark neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 50. Denmark neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 51. Denmark neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 52. Denmark neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 53. Asia Pacific neurovascular devices market, by country, 2018 - 2030 (USD Million)
  • Table 54. Asia Pacific neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 55. Asia Pacific neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 56. Asia Pacific neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 57. Asia Pacific neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 58. China neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 59. China neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 60. China neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 61. China neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 62. Japan neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 63. Japan neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 64. Japan neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 65. Japan neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 66. India neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 67. India neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 68. India neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 69. India neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 70. Australia neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 71. Australia neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 72. Australia neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 73. Australia neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 74. South Korea neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 75. South Korea neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 76. South Korea neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 77. South Korea neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 78. Latin America neurovascular devices market, by country, 2018 - 2030 (USD Million)
  • Table 79. Latin America neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 80. Latin America neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 81. Latin America neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 82. Latin America neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 83. Brazil neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 84. Brazil neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 85. Brazil neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 86. Brazil neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 87. Mexico neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 88. Mexico neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 89. Mexico neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 90. Mexico neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 91. Argentina neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 92. Argentina neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 93. Argentina neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 94. Argentina neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 95. Middle East & Africa neurovascular devices market, by country, 2018 - 2030 (USD Million)
  • Table 96. Middle East & Africa neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 97. Middle East & Africa neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 98. Middle East & Africa neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 99. Middle East & Africa neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 100. South Africa neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 101. South Africa neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 102. South Africa neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 103. South Africa neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 104. Saudi Arabia neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 105. Saudi Arabia neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 106. Saudi Arabia neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 107. Saudi Arabia neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 108. UAE neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 109. UAE neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 110. UAE neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 111. UAE neurovascular devices market, by end use, 2018 - 2030 (USD Million)
  • Table 112. Kuwait neurovascular devices market, by device, 2018 - 2030 (USD Million)
  • Table 113. Kuwait neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
  • Table 114. Kuwait neurovascular devices market, by size, 2018 - 2030 (USD Million)
  • Table 115. Kuwait neurovascular devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. Neurovascular devices market segmentation
  • Fig 2. Market research process
  • Fig 3. Information procurement
  • Fig 4. Primary research pattern
  • Fig 5. Market research approaches
  • Fig 6. Value-chain-based sizing & forecasting
  • Fig 7. QFD modeling for market share assessment
  • Fig 8. Market formulation & validation
  • Fig 9. Market outlook (2024)
  • Fig 10. Segment Outlook
  • Fig 11. Strategy framework
  • Fig 12. Penetration & growth prospect mapping
  • Fig 13. Market driver relevance analysis (Current & future impact)
  • Fig 14. Market restraint relevance analysis (Current & future impact)
  • Fig 15. Porter's five forces analysis
  • Fig 16. SWOT analysis, by factor (political & legal, economic and technological)
  • Fig 17. Neurovascular devices market: Device movement analysis
  • Fig 18. Neurovascular devices market device outlook: Key takeaways
  • Fig 19. Cerebral embolization and aneurysm coiling devices market, 2018 - 2030 (USD Million)
  • Fig 20. Embolic coils market, 2018 - 2030 (USD Million)
  • Fig 21. Flow diverters market, 2018 - 2030 (USD Million)
  • Fig 22. Liquid embolic agents market, 2018 - 2030 (USD Million)
  • Fig 23. Cerebral angioplasty and stenting systems market, 2018 - 2030 (USD Million)
  • Fig 24. Carotid artery stents market, 2018 - 2030 (USD Million)
  • Fig 25. Embolic protection systems devices market, 2018 - 2030 (USD Million)
  • Fig 26. Neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig 27. Clot retrieval devices market, 2018 - 2030 (USD Million)
  • Fig 28. Suction devices market, 2018 - 2030 (USD Million)
  • Fig 29. Vascular snares market, 2018 - 2030 (USD Million)
  • Fig 30. Support devices market, 2018 - 2030 (USD Million)
  • Fig 31. Micro catheters market, 2018 - 2030 (USD Million)
  • Fig 32. Guidewires market, 2018 - 2030 (USD Million)
  • Fig 33. Trans radial access devices market, 2018 - 2030 (USD Million)
  • Fig 34. Neurovascular devices market: Therapeutic application movement analysis
  • Fig 35. Neurovascular devices market therapeutic applications outlook: Key takeaways
  • Fig 36. Stroke market, 2018 - 2030 (USD Million)
  • Fig 37. Cerebral artery stenosis market, 2018 - 2030 (USD Million)
  • Fig 38. Cerebral aneurysm market, 2018 - 2030 (USD Million)
  • Fig 39. Aneurysmal subarachnoid hemorrhage market, 2018 - 2030 (USD Million)
  • Fig 40. Others market, 2018 - 2030 (USD Million)
  • Fig 41. Neurovascular devices market: Size movement analysis
  • Fig 42. Neurovascular devices market size outlook: Key takeaways
  • Fig 43. 0.027"market, 2018 - 2030 (USD Million)
  • Fig 44. 0.021" market, 2018 - 2030 (USD Million)
  • Fig 45. 0.021" market, 2018 - 2030 (USD Million)
  • Fig 46. 0.071" market, 2018 - 2030 (USD Million)
  • Fig 47. 0.046" market, 2018 - 2030 (USD Million)
  • Fig 48. 0.019" market, 2018 - 2030 (USD Million)
  • Fig 49. 0.013" market, 2018 - 2030 (USD Million)
  • Fig 50. 0.058" market, 2018 - 2030 (USD Million)
  • Fig 51. 0.068" market, 2018 - 2030 (USD Million)
  • Fig 52. Others market, 2018 - 2030 (USD Million)
  • Fig 53. Neurovascular devices market: End use movement analysis
  • Fig 54. Neurovascular devices market end use outlook: Key takeaways
  • Fig 55. Hospital market, 2018 - 2030 (USD Million)
  • Fig 56. Specialty clinics market, 2018 - 2030 (USD Million)
  • Fig 57. Others market, 2018 - 2030 (USD Million)
  • Fig 58. Regional outlook, 2019 & 2027
  • Fig 59. Regional market place: Key takeaways
  • Fig 60. North America, SWOT, by PEST
  • Fig 61. Europe, SWOT, by PEST
  • Fig 62. Asia Pacific,, SWOT, by PEST
  • Fig 63. Latin America, SWOT, by PEST
  • Fig 64. Middle East and Africa,, SWOT, by PEST
  • Fig 65. North America neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 66. U.S. neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 67. Canada neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 68. Europe neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 69. UK. neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 70. Germany neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 71. France neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 72. Italy neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 73. Spain neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 74. Norway neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 75. Denmark neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 76. Sweden neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 77. Asia Pacific neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 78. Japan neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 79. China neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 80. India neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 81. Australia neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 82. South Korea neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 83. Thailand neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 84. Latin America neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 85. Brazil neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 86. Mexico neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 87. Argentina neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 88. MEA neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 89. South Africa neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 90. Saudi Arabia neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 91. UAE neurovascular devices market, 2018 - 2030 (USD Million)
  • Fig 92. Kuwait neurovascular devices market, 2018 - 2030 (USD Million)